Ambev reports 2024 annual results, files Form 20-F

Ambev S.A. [B3: ABEV3; NYSE: ABEV], the Brazil-based beverage company with a market capitalization of $35.4 billion and annual revenue of $14.5 billion, has announced the filing of its annual report on Form 20-F for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission (SEC) today. According to InvestingPro analysis, the company currently appears undervalued based on its Fair Value metrics. This key document, which provides a comprehensive overview of the company’s financial performance for the past year, is now accessible to the public on both the SEC’s website and Ambev’s investor relations page.

The Form 20-F filing is a requirement for foreign private issuers with listed equity shares on American exchanges and contains detailed information about the company’s business, including audited financial statements, risk factors, and management’s discussion and analysis of financial condition and results of operations.

In line with Ambev’s commitment to transparency, ADR (American Depositary Receipt) holders are entitled to request a hard copy of the complete audited financial statements free of charge. The company maintains a strong financial position, with InvestingPro data showing an impressive Financial Health Score of 3.16 (rated as GREAT) and a robust year-to-date return of 18.4%. This offer aims to ensure that all investors, regardless of their preferred format, have equal access to the company’s financial disclosures.

Ambev, recognized for its diverse portfolio of beverages, is categorized under the Beverages industry with a Standard Industrial Classification (SIC) code of 2080. The company’s business address and contact information were also confirmed in the filing, but in keeping with professional reporting standards, these details are omitted from this article.

Investors and stakeholders interested in examining Ambev’s financial details and operational insights for the year 2024 are encouraged to visit the company’s investor relations website or the SEC’s EDGAR database for the full report. For those seeking deeper analysis, InvestingPro offers a comprehensive Research Report on Ambev, part of its coverage of over 1,400 top stocks, with the next earnings announcement expected on May 8, 2025.

This article is based on a press release statement and aims to provide investors with a concise and factual summary of Ambev’s latest financial disclosures as required by securities regulations.

In other recent news, Ambev S.A. has experienced notable developments in its stock evaluations. BofA Securities downgraded Ambev’s stock rating from Buy to Neutral, citing valuation concerns amid an anticipated deceleration in growth. The firm’s revised price target for the beverage company is now BRL 13.20, down from BRL 15.80, reflecting expectations of a slowdown in Ambev’s EBITDA growth rate from 2024 to 2026. Despite a strong performance in recent years, BofA Securities projects a less favorable growth trajectory moving forward.

Meanwhile, Bernstein analysts have adjusted their price target for Ambev shares to $2.57 from a previous $3.08, though they maintained an Outperform rating. This adjustment considers the impact of the weaker Brazilian Real and updated macroeconomic data. Bernstein highlighted Ambev’s solid fundamentals, including an 11% normalized earnings per share growth rate and a strong net cash position. The analysts believe these strengths should support Ambev’s market performance despite the revised price target. These updates from BofA Securities and Bernstein provide investors with fresh insights into Ambev’s financial outlook amid changing economic conditions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.